Yikes!
Back to the lab with that one I guess.
"Do not take with alcohol" might not be a mere suggestion, as I had supposed.
He is not an animal. He is her boyfriend.
I saw the original article last night. This is really a horrible situation. All the volunteers reacted badly, was the drug contaminated with something else?
I don't know what Britain's drug testing programs are like, but maybe our FDA ain't so bad?
Prayers for the volunteers.
[This is a drug they have never tested on humans before so they don't know what they are dealing with.]
Yeah. Those jerks should have tried it on humans before trying it on her boyfriend.
Wouldn't you hate to be the attorney that drafted that "no liability" contract for those VOLUNTEERS. I sure hope its solid.
Moon Over Myfanwy.
She's pretty cute, and I think she'll be available pretty soon.
I hope he recovers, but not the greatest hobby if you ask me.
I guess that the name "Myfanwy" is of Welsh origin, but how is it pronounced?
Good Lord! A drug experiment gone horribly wrong. That's why we should use animals for medical experiments. This is going to be really bad for Parexel International and Tegenero AG.
More information and Thursday update:
http://news.yahoo.com/s/ap/20060316/ap_on_re_eu/britain_drug_trial_6
LONDON - Six men who became ill during a drug trial remained in serious condition in a London hospital Thursday.
Two of the men were listed in critical condition, Northwick Park Hospital said in a statement.
Raste Khan one of two men given a placebo in the trial said the six had been stricken within a few minutes of receiving the drug.
"Everyone was continuously vomiting," Khan said in an interview broadcast Thursday on Sky News.
They were "fainting, coming back to consciousness. Again I assume they had headaches, because a lot of them were kind of like holding their heads," he said.
One man was screaming and complained of pain in his back, Khan said.
The six men had been given does of TGN1412, a monoclonal antibody developed by TeGenero AG of Wuerzburg, Germany, for treatment of autoimmune and inflammatory diseases and leukemia.
(excerpt)